arrow
M

Mercedes Iñarrairaegui

Clínica Universidad de Navarra
H指数:39
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Invasive fungal infections after liver transplantation: Risk factors and impact on mortality in a retrospective single-center cohort with propensity score matching

肝移植后侵袭性真菌感染:基于倾向性评分匹配的单中心回顾性队列研究中的危险因素及对死亡率的影响

2026-08-220
OAAI
Longitudinal biomarker progression and validation for predicting operational tolerance in a prospective multicenter liver transplantation immunosuppression withdrawal trial

纵向生物标志物进展及其验证:预测前瞻性多中心肝移植免疫抑制撤药试验中的操作耐受性

2025-12-080
PRE
Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy

突破接受免疫治疗晚期HCC患者进入重症监护的障碍

2025-08-120
OAAI
Phosphatidylserine as a tumor target for CAR-T cell therapy

磷脂酰丝氨酸作为CAR-T细胞疗法的肿瘤靶点

2025-02-230
OA
Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression

肝细胞癌中全面的计算机CpG甲基化分析可识别与基因表达无关的组织和肿瘤类型特异性标记

2024-09-210
OAAI
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients
2023-03-202
PRE
Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019

冠状病毒病2019后12个月肝移植受者的长期新型冠状病毒特异性体液免疫降低

2022-01-178
PRE
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
2021-08-0132
OAAI
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules (vol 70, pg 874, 2019)
2021-02-010
OAAI
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients
2021-01-01266
OAAI
Hepavac-101 first-in-man clinical trial of a multi-peptide-based vaccine for hepatocellular carcinoma
2020-08-152
PRE